BOPA’s Let’s Talk About SACT Podcast – Number 16 top podcast in cancer and number 6 oncology podcast in the UK

BOPA is ecstatic to announce that the “Let’s Talk About SACT” podcast has been selected by FeedSpot panellists as one of the Top 35 UK Cancer Podcasts on the web. It is currently listed as Number 16 top podcast in cancer and number 6 oncology podcast in the UK. As always, thank you to all our guests, listeners and for those who have provided feedback. Please continue to share the podcast with colleagues, friends, and anyone who may find it useful or interesting!

Let’s Talk About SACT – a BOPA Podcast – BOPA

 

Latest News

By BOPA Executive Committee on 1st August 2026

4 Weeks left to Nominate your BOPA Fellowship

4 Weeks left to nominate a BOPA Fellow for 2026. The BOPA Fellowship Scheme Policy has been updated for a clearer nomination and selection process including specific criteria for assessing the nominated individuals.…

Read article
By BOPA Executive Committee on 31st July 2026

Supporting awareness of occupational risks from hazardous medicinal products – BOPA and PASG

Dear BOPA Member, Every day, oncology pharmacy professionals play a vital role in ensuring patients receive safe and effective SACT. Whether preparing, dispensing, transporting or supporting the administration of hazardous…

Read article
By BOPA Executive Committee on 29th July 2026

Publication ALERT – Managing aseptic capacity pressures in systemic anti-cancer therapy services: A national mixed-methods evaluation of UK SACT board guidance implementation

BOPA Publication: Managing aseptic capacity pressures in systemic anti-cancer therapy services: A national mixed-methods evaluation of UK SACT board guidance implementation – Annette (Netty) Cracknell, Dharmisha Chauhan, Lisa Barrott, Emma…

Read article
By BOPA on 24th July 2026

Call for BOPA Award nominations – 1 week left!

It’s awards time – call for nominations! We have had lots of positive feedback from the introduction of the awards dinner at the annual conference, and we are now calling…

Read article